Exploring vaccine to block maternal CMV transmission

A study out of Weill Cornell Medicine and Oregon Health & Science University provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus across the placenta to babies before they're born.

‘Flipping’ switch boosts stem cell numbers for therapies

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators. 

Possible biomarker identified for Crohn’s disease with arthritis type

People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, according to a new study by Weill Cornell Medicine researchers.

$10.5M gift to Cornell will fund research using Empire AI

The gift from philanthropist Tom Secunda, co-founder of Bloomberg L.P., will help fund artificial intelligence-related research at Cornell Tech in New York City and at the Cornell Ann S. Bowers College of Computing and Information Science in Ithaca.

Study: ‘Ball and chain’ mechanism inactivates key ion channel

A new study has unveiled a precise picture of how an ion channel found in most mammalian cells regulates its own function with a “ball-and-chain” channel-plugging mechanism, according to investigators at Weill Cornell Medicine.

AI system can analyze serial medical images

A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, which may be useful across a wide range of medical and scientific applications.

How to beat the winter blues and more: A Q&A with Cornell Tech’s new therapist Sarah Rubenstein-Gillis

In the fall of 2024, Cornell Tech welcomed a counselor, Sarah Rubenstein-Gillis, dedicated to students on its campus in New York City.

Around Cornell

Islet-transplantation procedure shows promises against T1 diabetes

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.

New therapy may effectively control HIV in Uganda

A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.